Company Overview
- Headquarters
- 22 Strathmore Rd, Natick MA
- Website
- affyimmune.com
- in****@affyimmune.com
- Phone
- (508) 654-3600
- Employees
- 37
- Founded in
- 2016
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is AffyImmune Therapeutics
AffyImmune Therapeutics is a clinical-stage biotechnology company based in Natick, Massachusetts. Founded in 2016, the company employs 37 people. AffyImmune specializes in optimizing CAR T cells for the treatment of solid tumors using its proprietary Tune & Track platform. Their lead product, AIC100, is designed to spare healthy cells through a unique affinity-tuning process, enhancing both its safety and efficacy. AIC100's initial indication is for refractory thyroid cancer, a condition with a poor prognosis and limited treatment options. The antigen targeted by AIC100 is also overexpressed in several other cancers, including stomach, triple negative breast cancer, and others, suggesting potential applications beyond thyroid cancer. For more information, visit AffyImmune Therapeutics' website at affyimmune.com.
Company Leadership
AffyImmune Therapeutics Tech Stack
Companies Similar to AffyImmune Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to AffyImmune Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |